Feb 18, 2021
Evox Therapeutics completes £69.2 million Series C financing
Nov 24, 2020
Evox Therapeutics expands its existing exosome patent portfolio
Nov 17, 2020
Evox Therapeutics announces launch of strategic collaboration with the University of Oxford
Oct 13, 2020
Evox Therapeutics appoints Dr David Lowe as Vice President of Research
Jul 15, 2020
Evox Therapeutics Expands Existing Exosome Patent Portfolio With Further Grant Covering Exosomes for RNA Therapeutics
Jun 09, 2020
Evox Therapeutics Announces a Multi-target RNAi and Antisense Research Collaboration and License Agreement With Lilly
May 27, 2020
Evox Therapeutics Appoints Martin Andrews as Non-Executive Director
May 19, 2020
Evox Therapeutics Appoints Dr Sonya Montgomery as Chief Medical Officer
May 14, 2020
Evox Therapeutics Appoints Paul Carter as Non-executive Chairman
Mar 26, 2020
Evox Therapeutics and Takeda Sign Multi-target Rare Disease Collaboration
Aug 07, 2019
Evox Therapeutics Granted Key Exosome Patents Covering RNA Therapeutics and Targeted Drug Delivery
Mar 22, 2019
Evox Therapeutics Awarded £1.5 Million in Funding From Innovate UK
Dec 20, 2018
Evox Therapeutics Appoints Edwin Moses as Non-Executive Chairman
Dec 10, 2018
Evox Therapeutics to Expand Its Work on Cell-targeted Delivery of Nucleic Acid-based Drugs
Dec 03, 2018
Evox Therapeutics Named in The Sunday Times Fast Track Disruptors to Watch
Nov 13, 2018
Evox Therapeutics Wins Funding From Duchenne UK to Explore Exosome-Mediated Delivery of Dystrophin
Sep 03, 2018
Evox Therapeutics Completes £35.5 Million Series B Financing
Dec 19, 2017
Evox Therapeutics to Collaborate with Boehringer Ingelheim on Exosome-Mediated Drug Delivery
Nov 13, 2017
Evox Therapeutics Appoints Antonin de Fougerolles as Chief Executive Officer